title: Contribution of the OATP1B subfamily to cancer biology and treatment.
authors.affiliation: Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA.
authors.forename: T M
authors.initials: TM
authors.lastname: Sissung
authors.forename: K M
authors.initials: KM
authors.lastname: Reece
authors.forename: S
authors.initials: S
authors.lastname: Spencer
authors.forename: W D
authors.initials: WD
authors.lastname: Figg
mesh_terms: D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008099:Liver / Q000378:metabolism; D027381:Liver-Specific Organic Anion Transporter 1; D009369:Neoplasms / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D027361:Organic Anion Transporters / Q000235:genetics / Q000378:metabolism*; D029362:Organic Anion Transporters, Sodium-Independent / Q000235:genetics / Q000378:metabolism*; D000074542:Solute Carrier Organic Anion Transporter Family Member 1B3
chemical_list: D027381:Liver-Specific Organic Anion Transporter 1; D027361:Organic Anion Transporters; D029362:Organic Anion Transporters, Sodium-Independent; C503999:SLCO1B1 protein, human; C421209:SLCO1B3 protein, human; D000074542:Solute Carrier Organic Anion Transporter Family Member 1B3